These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 20699026)
21. Pharmacogenetics of adverse effects due to antiretroviral drugs. Vidal F; Gutiérrez F; Gutiérrez M; Olona M; Sánchez V; Mateo G; Peraire J; Viladés C; Veloso S; López-Dupla M; Domingo P AIDS Rev; 2010; 12(1):15-30. PubMed ID: 20216907 [TBL] [Abstract][Full Text] [Related]
22. Polymorphism of human cytochrome P450 enzymes and its clinical impact. Zhou SF; Liu JP; Chowbay B Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967 [TBL] [Abstract][Full Text] [Related]
23. Overview of the pharmacoeconomics of pharmacogenetics. Dervieux T; Bala MV Pharmacogenomics; 2006 Dec; 7(8):1175-84. PubMed ID: 17184205 [TBL] [Abstract][Full Text] [Related]
24. Pharmacogenetics of anticancer drug sensitivity in non-small cell lung cancer. Danesi R; de Braud F; Fogli S; de Pas TM; Di Paolo A; Curigliano G; Del Tacca M Pharmacol Rev; 2003 Mar; 55(1):57-103. PubMed ID: 12615954 [TBL] [Abstract][Full Text] [Related]
26. Should we be 'pushing meds'? The implications of pharmacogenomics. Bray J; Clarke C; Brennan G; Muncey T J Psychiatr Ment Health Nurs; 2008 Jun; 15(5):357-64. PubMed ID: 18454820 [TBL] [Abstract][Full Text] [Related]
27. Transporters and drug therapy: implications for drug disposition and disease. Ho RH; Kim RB Clin Pharmacol Ther; 2005 Sep; 78(3):260-77. PubMed ID: 16153397 [TBL] [Abstract][Full Text] [Related]
28. Pharmacogenomics in breast cancer: current trends and future directions. Wajapeyee N; Somasundaram K Curr Opin Mol Ther; 2004 Jun; 6(3):296-301. PubMed ID: 15264432 [TBL] [Abstract][Full Text] [Related]
29. Pharmacogenetics of tacrolimus and sirolimus in renal transplant patients: from retrospective analyses to prospective studies. Anglicheau D; Legendre C; Thervet E Transplant Proc; 2007 Sep; 39(7):2142-4. PubMed ID: 17889118 [TBL] [Abstract][Full Text] [Related]
30. Considerations for safety pharmacogenetics in clinical practice. Frueh FW Drug Discov Today; 2011 Oct; 16(19-20):898-901. PubMed ID: 21888988 [TBL] [Abstract][Full Text] [Related]
31. Pharmacogenetics in older people: what we know and what we need to know. Seripa D; Paroni G; Urbano M; Santini SA; D'Onofrio G; Pilotto A J Nephrol; 2012; 25 Suppl 19():S38-47. PubMed ID: 22476963 [TBL] [Abstract][Full Text] [Related]
32. [Pharmacogenetic aspects of current pharmacotherapy]. Slanar O; Zima T Cas Lek Cesk; 2010; 149(10):472-5. PubMed ID: 21121137 [TBL] [Abstract][Full Text] [Related]
33. Preemptive genotyping trialed to prevent adverse drug reactions. Dolgin E Nat Med; 2011 Nov; 17(11):1323. PubMed ID: 22064389 [No Abstract] [Full Text] [Related]
34. Clinically relevant genetic variations in drug metabolizing enzymes. Pinto N; Dolan ME Curr Drug Metab; 2011 Jun; 12(5):487-97. PubMed ID: 21453273 [TBL] [Abstract][Full Text] [Related]
35. [Xenobiotic-metabolizing polymorphic enzymes. An opportunity for individualized drug treatment]. Lhermitte M; Allorge D; Broly F Bull Acad Natl Med; 2006 Jan; 190(1):55-69; discussion 69-73. PubMed ID: 16878446 [TBL] [Abstract][Full Text] [Related]
38. Pharmacogenetics of aldo-keto reductase 1C (AKR1C) enzymes. Alshogran OY Expert Opin Drug Metab Toxicol; 2017 Oct; 13(10):1063-1073. PubMed ID: 28871815 [TBL] [Abstract][Full Text] [Related]
39. Pharmacogenomics and pharmacogenetics for the intensive care unit: a narrative review. MacKenzie M; Hall R Can J Anaesth; 2017 Jan; 64(1):45-64. PubMed ID: 27752976 [TBL] [Abstract][Full Text] [Related]
40. Challenges in current drug delivery from the potential application of pharmacogenomics and personalized medicine in clinical practice. Vizirianakis IS Curr Drug Deliv; 2004 Jan; 1(1):73-80. PubMed ID: 16305372 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]